Annotating Human P‐Glycoprotein Bioassay Data
Open Access
- 7 August 2012
- journal article
- research article
- Published by Wiley in Molecular Informatics
- Vol. 31 (8) , 599-609
Abstract
Huge amounts of small compound bioactivity data have been entering the public domain as a consequence of open innovation initiatives. It is now the time to carefully analyse existing bioassay data and give it a systematic structure. Our study aims to annotate prominent in vitro assays used for the determination of bioactivities of human P‐glycoprotein inhibitors and substrates as they are represented in the ChEMBL and TP‐search open source databases. Furthermore, the ability of data, determined in different assays, to be combined with each other is explored. As a result of this study, it is suggested that for inhibitors of human P‐glycoprotein it is possible to combine data coming from the same assay type, if the cell lines used are also identical and the fluorescent or radiolabeled substrate have overlapping binding sites. In addition, it demonstrates that there is a need for larger chemical diverse datasets that have been measured in a panel of different assays. This would certainly alleviate the search for other inter‐correlations between bioactivity data yielded by different assay setups.Keywords
Funding Information
- Funded Access
- Innovative Medicines Initiative Joint Undertaking (n° 115002 (eTOX) and 115191 (Open PHACTS))
- European Union’s Seventh Framework Programme (FP7/2007-2013)
- EFPIA companies
This publication has 32 references indexed in Scilit:
- Taking Open Innovation to the Molecular Level ‐ Strengths and LimitationsMolecular Informatics, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening resultsBMC Bioinformatics, 2011
- BioAssay Ontology Annotations Facilitate Cross-Analysis of Diverse High-Throughput Screening Data SetsSLAS Discovery, 2011
- A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction FieldsJournal of Medicinal Chemistry, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- An overview of the PubChem BioAssay resourceNucleic Acids Research, 2009
- Chemical Entities of Biological Interest: an updateNucleic Acids Research, 2009
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002